Waning of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven Months

被引:5
|
作者
Lea, C. Suzanne [1 ]
Simeonsson, Kristina [1 ,2 ]
Kipp, Aaron M. [1 ]
McNeill, Charleen [3 ,7 ]
Wilcox, Lisa [3 ]
Irish, William [4 ]
Morris, Hannah [2 ]
Diaz, Omar M. [1 ]
Fallon, John T. [5 ]
Roper, Rachel L. [6 ]
机构
[1] East Carolina Univ, Brody Sch Med, Dept Publ Hlth, Greenville, NC 27834 USA
[2] East Carolina Univ, Brody Sch Med, Dept Pediat, Greenville, NC 27834 USA
[3] East Carolina Univ, Coll Nursing, Greenville, NC 27834 USA
[4] East Carolina Univ, Brody Sch Med, Dept Surg, Greenville, NC 27834 USA
[5] East Carolina Univ, Brody Sch Med, Dept Pathol, Greenville, NC 27834 USA
[6] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA
[7] Univ Oklahoma, Fran & Earl Ziegler Coll Nursing, Hlth Sci Ctr, Oklahoma City, OK 73117 USA
关键词
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); seroprevalence; young adults; longitudinal; nucleocapsid protein; spike protein; COVID-19; INFECTIONS; UNIVERSITY; RESPONSES; CAMPUS;
D O I
10.3390/vaccines10091532
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We conducted a longitudinal study to estimate immunity produced in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among university students over seven months. Methods: All participants were attending a public university and resided in Pitt County, North Carolina. University students enrolled weekly for 10 weeks between 26 August 2020 and 28 October 2020, resulting in 136 young adults completing at least one study visit by 17 November 2020. Enrolled students completed an online survey and nasal swab collection at two-week intervals and monthly blood collection between 26 August 2020 and 31 March 2021. Results: Amongst 695 serum samples tested during follow-up, the prevalence of a positive result for anti-nucleocapsid antibodies (N-IgG) was 9.78%. In 22 students with more than one positive N-IgG serum sample, 68.1% of the group lost persistence of N-IgG below the positive threshold over 140 days. Anti-spike IgG antibodies were significantly higher among 11 vaccinated compared to 10 unvaccinated. Conclusions: In healthy young adults, N-IgG wanes below the detectable threshold within five months. S-IgG titer remained consistently elevated months after infection, and significantly increased after vaccination.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021
    Justman, Jessica
    Skalland, Timothy
    Moore, Ayana
    Amos, Christopher I.
    Marzinke, Mark A.
    Zangeneh, Sahar Z.
    Kelley, Colleen F.
    Singer, Rebecca
    Mayer, Stockton
    Hirsch-Moverman, Yael
    Doblecki-Lewis, Susanne
    Metzger, David
    Barranco, Elizabeth
    Ho, Ken
    Marques, Ernesto T. A.
    Powers-Fletcher, Margaret
    Kissinger, Patricia J.
    Farley, Jason E.
    Knowlton, Carrie
    Sobieszczyk, Magdalena E.
    Swaminathan, Shobha
    Reed, Domonique
    Tapsoba, Jean De Dieu
    Emel, Lynda
    Bell, Ian
    Yuhas, Krista
    Schrumpf, Leah
    Mkumba, Laura
    Davis, Jontraye
    Lucas, Jonathan
    Piwowar-Manning, Estelle
    Ahmed, Shahnaz
    EMERGING INFECTIOUS DISEASES, 2024, 30 (02) : 245 - 254
  • [42] Socioeconomic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort Study
    Lam, Tanya
    Saso, Anja
    Ortiz, Arturo Torres
    Hatcher, James
    Woodman, Marc
    Chandran, Shruthi
    Thistlethwayte, Rosie
    Best, Timothy
    Johnson, Marina
    Wagstaffe, Helen
    Mai, Annabelle
    Buckland, Matthew
    Gilmour, Kimberly
    Goldblatt, David
    Grandjean, Louis
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (03) : 594 - 602
  • [43] Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort
    Berenguer, Juan
    Diez, Cristina
    Martin-Vicente, Maria
    Mican, Rafael
    Perez-Elias, Maria J.
    Garcia-Fraile, Lucio J.
    Vidal, Francisco
    Suarez-Garcia, Ines
    Podzamczer, Daniel
    Del Romero, Jorge
    Pulido, Federico
    Iribarren, Jose A. .
    Gutierrez, Felix
    Poveda, Eva
    Galera, Carlos
    Izquierdo, Rebeca
    Asensi, Victor
    Portilla, Joaquin
    Lopez, Juan C.
    Arribas, Jose R.
    Moreno, Santiago
    Gonzalez-Garcia, Juan
    Resino, Salvador
    Jarrin, Inmaculada
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (11) : 1678 - 1684
  • [44] Population-based seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city
    Prakash, Om
    Solanki, Bhavin
    Sheth, Jay
    Oza, Divyang
    Kadam, Mina
    Vyas, Sheetal
    Shukla, Aparajita
    Pethani, Jayshri
    Tiwari, Hemant
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (06) : 2363 - 2368
  • [45] Overview of SARS-CoV-2 infection in adults living with HIV
    Ambrosioni, Juan
    Blanco, Jose Luis
    Reyes-Uruena, Juliana M.
    Davies, Mary-Ann
    Sued, Omar
    Marcos, Maria Angeles
    Martinez, Esteban
    Bertagnolio, Silvia
    Alcami, Jose
    Miro, Jose M.
    LANCET HIV, 2021, 8 (05): : e294 - e305
  • [46] Nationwide study of rates of reinfection with SARS-CoV-2 among adults in Kuwait
    Al-Ahmad, Mona
    Alowayesh, Maryam
    Al Awadi, Abdullah
    Alghounaim, Mohammed
    Al Hashemi, Hashem
    Al Enezi, Laila
    Rawdhan, Hanouf
    Rodriguez-Bouza, Tito
    EASTERN MEDITERRANEAN HEALTH JOURNAL, 2023, 29 (02) : 146 - 150
  • [47] Field evaluation of seven SARS-COV-2 antigen assays
    Lim, Yong Kwan
    Kweon, Oh Joo
    Kim, Hye Ryoun
    Kim, Tae-Hyoung
    Lee, Mi-Kyung
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (02) : 199 - 202
  • [48] Stroke seven hours after SARS-CoV-2 vaccination
    Fiorini, Ana Claudia
    Scorza, Carla Alexandra
    Almeida, Antonio-Carlos G. de
    Scorza, Fulvio Alexandre
    Finsterer, Josef
    CLINICS, 2023, 78
  • [49] SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan
    Kanai, Daisuke
    Wakui, Hiromichi
    Haze, Tatsuya
    Azushima, Kengo
    Kinguchi, Sho
    Tsukamoto, Shunichiro
    Kanaoka, Tomohiko
    Urate, Shingo
    Toya, Yoshiyuki
    Hirawa, Nobuhito
    Kato, Hideaki
    Watanabe, Fumimasa
    Hanaoka, Kanako
    Hanaoka, Masaaki
    Mitsuhashi, Hiroshi
    Yamaguchi, Satoshi
    Ohnishi, Toshimasa
    Tamura, Kouichi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (10) : 988 - 996
  • [50] Adverse Life Trajectories Are a Risk Factor for SARS-CoV-2 IgA Seropositivity
    Holuka, Cyrielle
    Snoeck, Chantal J.
    Meriaux, Sophie B.
    Ollert, Markus
    Kruger, Rejko
    Turner, Jonathan D.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (10)